David Fajgenbaum of Every Cure, the nonprofit focused on AI-powered drug repurposing
| | |

The Cure Hiding in Plain Sight: How Every Cure Is Rewriting the Rules of Drug Discovery

Every Cure is a nonprofit using AI and drug repurposing to uncover treatments hidden inside existing medicines. Founded by physician-scientist David Fajgenbaum after a repurposed drug saved his own life,…

VO2 max testing and oxygen metabolism illustrating cardiorespiratory fitness as a longevity biomarker | Healthcare Discovery
| | |

Your VO2 Max May Be the Single Best Predictor of How Long You Will Live: What 3.8 Million People and 58 Clinical Trials Reveal About Cardiorespiratory Fitness and the Science of Living Longer

A meta-analysis of 3.8 million people shows that each one-MET increase in cardiorespiratory fitness reduces all-cause mortality by 14 percent. A 2026 Cochrane review of 58 clinical trials confirms HIIT…

Nutrition and metabolic health evidence guide | Healthcare Discovery
| |

The 10 Fundamentals Your Body Already Knows: What Modern Metabolic Science Is Finally Confirming

Modern metabolic science, continuous glucose monitors, and wearable technology are confirming what ancient healers understood for millennia: optimal health comes down to mastering the fundamentals of nutrition, breath, recovery, and…

Immune cells clearing damaged mitochondria through mitophagy as urolithin A supports immune rejuvenation
| | |

Your Immune System Is Aging Because Your Mitochondria Are Failing: How Mitophagy Activation Is Reversing Immune Decline in Clinical Trials

A landmark clinical trial published in Nature Aging shows that urolithin A, a natural mitophagy activator, rejuvenated immune cell populations in middle-aged adults in just 28 days. The MitoImmune trial…

AI healthcare learning utility and closed loop care | Healthcare Discovery
| |

The Longevity Toolkit Takes Shape: AI Drug Discovery, Biological Age Clocks, and Microbiome Science Converge

A generative AI-designed drug has delivered clinical proof in a Phase IIa trial, while new biological age clocks and microbiome science are completing the precision longevity toolkit. Here is what…

Blood sample vials in a clinical laboratory setting, representing the p-tau217 blood test revolution in Alzheimer's disease diagnosis
| | |

A Simple Blood Test Can Now Detect Alzheimer’s Years Before Symptoms: How the P-Tau217 Revolution Is Rewriting Diagnosis

A wave of FDA-cleared blood tests measuring phosphorylated tau 217 is transforming Alzheimer’s diagnosis from expensive brain scans and spinal taps into a routine blood draw at your doctor’s office….

How to read a healthcare AI press release | Healthcare Discovery
| |

Epigenetic Reprogramming Goes Human: Three Breakthroughs Signal a Turning Point for Longevity Science

The first human trial of partial epigenetic reprogramming has launched, an AI platform published in Cell is accelerating longevity drug discovery, and a landmark NEJM trial proves cardiovascular primary prevention…

Strength training signals flowing into deep sleep waves and recovery biology
| | |

Strength Training Is the Most Underrated Sleep Aid in Medicine: What 86 Clinical Trials and 7,276 Participants Reveal About Lifting Weights and Deep Sleep

A 2025 network meta-analysis of 86 clinical trials and 7,276 participants reveals that resistance training significantly improves sleep quality, increases deep slow-wave sleep, reduces anxiety and inflammatory markers, and triggers…